Novartis is on the final straight to approval of its spinal muscular atrophy (SMA) gene therapy Zolgensma in the EU, after getting a recommendation for approval from the CHMP. The positive opinion ...
The central government announced a complete GST exemption on 36 lifesaving medicines on Monday September 22, covering cancer therapies, treatments for rare genetic disorders, and drugs for chronic ...
SMA-20 Crossed Above SMA-50 Stocks- 20 day moving avergae above 50 day moving average: The primary application of Simple Moving Average is for analyzing stock trends Multiply the power of your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback